Nutex Health (NUTX) Competitors $84.00 -0.81 (-0.96%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$82.04 -1.97 (-2.34%) As of 08/1/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUTX vs. GDRX, DFIN, PLTK, PINC, UPWK, OLO, XMTR, LZ, PHR, and NVEEShould you be buying Nutex Health stock or one of its competitors? The main competitors of Nutex Health include GoodRx (GDRX), Donnelley Financial Solutions (DFIN), Playtika (PLTK), Premier (PINC), Upwork (UPWK), OLO (OLO), Xometry (XMTR), LegalZoom.com (LZ), Phreesia (PHR), and NV5 Global (NVEE). These companies are all part of the "business services" industry. Nutex Health vs. Its Competitors GoodRx Donnelley Financial Solutions Playtika Premier Upwork OLO Xometry LegalZoom.com Phreesia NV5 Global Nutex Health (NASDAQ:NUTX) and GoodRx (NASDAQ:GDRX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk. Do institutionals & insiders hold more shares of NUTX or GDRX? 5.3% of Nutex Health shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 36.9% of Nutex Health shares are held by insiders. Comparatively, 4.5% of GoodRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, NUTX or GDRX? Nutex Health has a beta of -0.04, suggesting that its share price is 104% less volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500. Is NUTX or GDRX more profitable? Nutex Health has a net margin of 10.76% compared to GoodRx's net margin of 3.57%. Nutex Health's return on equity of 42.08% beat GoodRx's return on equity.Company Net Margins Return on Equity Return on Assets Nutex Health10.76% 42.08% 11.80% GoodRx 3.57%7.85%3.91% Which has preferable valuation & earnings, NUTX or GDRX? Nutex Health has higher earnings, but lower revenue than GoodRx. Nutex Health is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNutex Health$624.28M0.75$52.18M$11.897.06GoodRx$792.32M2.04$16.39M$0.0856.63 Do analysts prefer NUTX or GDRX? Nutex Health currently has a consensus price target of $262.50, suggesting a potential upside of 212.50%. GoodRx has a consensus price target of $6.55, suggesting a potential upside of 44.49%. Given Nutex Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Nutex Health is more favorable than GoodRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nutex Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00GoodRx 0 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.64 Does the media favor NUTX or GDRX? In the previous week, Nutex Health had 7 more articles in the media than GoodRx. MarketBeat recorded 9 mentions for Nutex Health and 2 mentions for GoodRx. GoodRx's average media sentiment score of 0.51 beat Nutex Health's score of 0.45 indicating that GoodRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nutex Health 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GoodRx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNutex Health beats GoodRx on 9 of the 17 factors compared between the two stocks. Get Nutex Health News Delivered to You Automatically Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUTX vs. The Competition Export to ExcelMetricNutex HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$471.13M$7.18B$5.49B$9.52BDividend YieldN/A2.90%4.73%4.09%P/E Ratio7.0664.1328.7823.81Price / Sales0.7533.83372.2066.04Price / Cash6.4425.7735.4557.96Price / Book2.268.618.275.54Net Income$52.18M$239.96M$3.25B$259.28M7 Day Performance-11.60%-5.48%-3.70%-4.64%1 Month Performance-31.31%-3.73%4.34%4.41%1 Year Performance1,065.05%18.27%25.90%17.95% Nutex Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUTXNutex Health2.7638 of 5 stars$84.00-1.0%$262.50+212.5%+981.1%$471.13M$624.28M7.061,150Short Interest ↑Gap DownGDRXGoodRx3.0441 of 5 stars$5.01+0.2%$6.55+30.6%-48.2%$1.79B$792.32M62.63950Positive NewsUpcoming EarningsDFINDonnelley Financial Solutions2.8054 of 5 stars$65.07+1.1%$71.33+9.6%-20.8%$1.78B$781.90M21.551,800Trending NewsEarnings ReportAnalyst DowngradePLTKPlaytika4.1399 of 5 stars$4.69+0.4%$7.68+63.7%-41.6%$1.75B$2.55B12.343,500News CoverageUpcoming EarningsPINCPremier2.1454 of 5 stars$21.12-0.2%$22.20+5.1%+1.4%$1.74B$1.35B37.052,900Positive NewsUPWKUpwork2.5468 of 5 stars$12.86-1.9%$18.67+45.2%+5.8%$1.73B$769.33M7.70850News CoveragePositive NewsUpcoming EarningsShort Interest ↑OLOOLO1.5447 of 5 stars$10.14flat$10.17+0.3%+92.8%$1.68B$284.94M507.25710Upcoming EarningsXMTRXometry2.2824 of 5 stars$32.84+0.7%$35.78+8.9%+127.8%$1.65B$545.53M-33.171,088News CoveragePositive NewsUpcoming EarningsShort Interest ↑LZLegalZoom.com0.8645 of 5 stars$9.23+1.7%$9.08-1.6%+36.5%$1.65B$681.88M54.291,220News CoveragePositive NewsUpcoming EarningsPHRPhreesia4.2023 of 5 stars$27.11+1.8%$32.27+19.0%+7.0%$1.58B$419.81M-36.632,082Gap DownNVEENV5 Global3.0803 of 5 stars$22.39-2.9%$25.67+14.6%-10.0%$1.55B$941.27M45.235,024News CoverageUpcoming EarningsHigh Trading Volume Related Companies and Tools Related Companies GoodRx Alternatives Donnelley Financial Solutions Alternatives Playtika Alternatives Premier Alternatives Upwork Alternatives OLO Alternatives Xometry Alternatives LegalZoom.com Alternatives Phreesia Alternatives NV5 Global Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUTX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutex Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutex Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
